Kymera Therapeutics
a year ago
Kymera TherapeuticsPosts3
IntroKymera Therapeutics stands at the forefront of clinical-stage biopharmaceutical innovation, introducing a groundbreaking modality known as "targeted protein degradation" (TPD). This transformative approach allows us to tackle traditionally undruggable targets and revolutionize disease treatment paradigms. Central to our advancements is the proprietary drug discovery engine, Pegasus, crafted by our skilled team. Pegasus facilitates the creation of highly selective, small molecule protein degraders, demonstrating potent activity across a diverse spectrum of disease indications.
200 Arsenal Yards Blvd suite 230, Watertown, MA 02472, USA
(857) 285-5300
Followers
No followers yet
